81 results
Page 4 of 5
8-K
EX-99.1
tkkpce fd3sqh0o4k
14 Nov 19
Motus GI Reports Third Quarter 2019 Financial Results and Provides Corporate Update
7:10am
8-K
EX-99.1
wex1xgkz 57si7myu
9 Aug 19
Motus GI Reports Second Quarter 2019 Financial Results and Provides Corporate Update
7:30am
424B5
n68rx98sh51d51b
27 Jun 19
Prospectus supplement for primary offering
4:06pm
424B5
u76pcu 7bx1s39xz
26 Jun 19
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
qeh8flsj
11 Jun 19
Motus GI Receives FDA Clearance to Market Pure-Vu® GEN2
7:35am
DEF 14A
kavog 2emqj
3 May 19
Definitive proxy
7:34am
S-3/A
0p9eh6jqw1eal
12 Apr 19
Shelf registration (amended)
8:48am
S-3
4h6x6
26 Mar 19
Shelf registration
4:42pm
424B4
f8ses32t5xe
20 Dec 18
Prospectus supplement with pricing info
4:48pm
8-K
EX-99.1
rjgb9p rw73nag
15 Nov 18
Regulation FD Disclosure
7:41am
8-K
EX-99.1
ihbehw0plf2gimglc
25 Sep 18
Departure of Directors or Certain Officers
7:05am
8-K
EX-99.1
humfl3 fa
14 Aug 18
Motus GI Reports 2018 Second Quarter Financial Results and Provides Business Update
8:06am
8-K
EX-99.1
6evoj
15 May 18
Motus GI Reports 2018 First Quarter Financial Results and Provides Business Update
7:41am
10-Q
5q4xu0texb8pmeb0cf
14 May 18
Quarterly report
12:00am